Alabama Senate Bill SB274

Alabama 2025 Regular Session

• Introduced: 4/1/25
• Refer: 4/1/25
• Report Pass: 4/9/25

Caption

Psychoactive derivatives of CBD; Possession prohibited; criminal penalties provided for violations

Impact

If enacted, SB274 would impose strict legal boundaries on the availability of these psychoactive cannabinoids within Alabama. It prescribes criminal penalties for violations, including class misdemeanors and felonies, depending on the nature and frequency of the offense. Specifically, the sale or distribution of these substances to individuals under the age of 21 would lead to significant legal ramifications, while individuals under 21 found in possession of these cannabinoids would face fines or community service, significantly tightening the legal framework around cannabinoid sales.

Summary

SB274 aims to amend existing Alabama law regarding the possession and sale of psychoactive cannabinoids, specifically cannabinoids that are derived from hemp, such as delta-8, delta-9, and delta-10 tetrahydrocannabinol. This bill seeks to prohibit the possession and sale of these psychoactive substances, with exceptions only for medical cannabis as per existing laws. The intended effect of SB274 is to enhance regulations concerning these cannabinoids, ostensibly to protect minors from potential harm associated with their use.

Contention

Discussion surrounding SB274 may revolve around concerns regarding personal freedom, public health, and the regulatory landscape of cannabis in Alabama. Supporters of the bill argue for public safety and the prevention of underage access to psychoactive substances, while opponents could raise issues regarding personal liberties and the efficacy of the bill in achieving its goals. Notably, there may be contention regarding the implications for medical marijuana users and how this legislation intersects with existing medical cannabis laws.